Avita Medical | 1811094D - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Accuray USD 91.79M 7.07M 2024-09
Celltrion KRW 2.01T 39.71B 2026-03
Clinuvel Pharmaceuticals AUD 16.58M 10.88M 2025-12
Cochlear AUD 568.4M 17.5M 2025-12
CSL USD 4.32B 1.35B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Mayne Pharma AUD 193.22M 5.64M 2024-06
Medical Developments International AUD 7.48M 174K 2025-12
Nanosonics AUD 46.45M 8.2M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 53K 14K 2025-12
Pacific Edge NZD 2.46M 1.29M 2026-06
Paradigm Biopharmaceuticals AUD 6.31M 58.85K 2025-12
Pharma Mar EUR 58.06M 6.87M 2026-06
Polynovo AUD 24.21M 945K 2025-12
PYC Therapeutics AUD 32.59M 8.52M 2025-12
Qiagen NV USD 398.35M 1.73M 2026-06
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 1.05B 1.1M 2026-03
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Telix Pharmaceuticals AUD 135.24M 5.72M 2025-12
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03